Spreadsheet: 0a8da264-cfba-44cf-985a-2390844eecfd
Sheet: Tb45

 | Estimated Vaccination Coverage^ with Individual Vaccines and Vaccination Series Among Children 19-35 Months of Age by Race/Ethnicity* -- US, National Immunization Survey, Q1/2010-Q4/2010†
[NAME] | US National | White only,                        non-Hispanic | Black only,                         non-Hispanic | Hispanic | American Indian or [NAME] only, non-Hispanic | Asian only, non-Hispanic | Native Hawaiian or other Pacific Islander only, non-Hispanic | Multiple Race, non-Hispanic
3+DTaP¥ | 95.0±0.6 | 95.1±0.8 | 95.3±1.5 | 95.1±1.4 | 97.3±2.2 | 95.7±2.9 | 96.9±3.5 | 92.4±3.5
4+DTaP‡ | 84.4±1.0 | 84.5±1.3 | 83.7±2.7 | 84.4±2.5 | 81.8±7.5 | 88.3±4.0 | NA | 82.8±4.8
3+Polio§ | 93.3±0.7 | 93.2±0.8 | 94.0±1.6 | 93.8±1.6 | 94.6±3.5 | 92.8±3.5 | 95.1±4.5 | 90.2±3.9
1+MMRll | 91.5±0.7 | 90.6±0.9 | 92.1±1.9 | 92.9±1.6 | 93.4±6.3 | 91.7±3.6 | 96.9±4.0 | 89.7±3.8
3+Hib¶ | 90.4±0.9 | 90.3±1.2 | 89.4±2.3 | 92.0±1.7 | 93.9±3.0 | 85.7±5.7 | 93.1±6.4 | 87.3±4.4
Hib-PS** | 92.2±0.8 | 92.3±1.1 | 90.9±2.2 | 93.3±1.5 | 95.7±2.7 | 89.0±5.3 | 94.4±5.8 | 90.4±3.8
Hib-FS†† | 66.8±1.3 | 67.5±1.6 | 65.4±3.4 | 64.8±3.1 | 77.1±7.4 | 69.5±6.8 | NA | 70.1±5.8
3+HepB‡‡ | 91.8±0.7 | 91.4±0.9 | 92.1±1.8 | 92.5±1.7 | 97.2±2.3 | 91.7±3.5 | 96.7±3.6 | 89.9±3.8
[NAME] dose§§ | 64.1±1.3 | 63.2±1.6 | 64.1±3.6 | 65.5±3.1 | 71.9±9.6 | 62.6±7.2 | NA | 64.4±6.4
1+Varllll | 90.4±0.8 | 88.9±1.1 | 91.5±2.0 | 92.3±1.8 | 95.7±2.7 | 92.5±3.4 | 92.7±6.8 | 88.9±3.9
3+PCV¶¶ | 92.6±0.8 | 92.8±0.9 | 92.6±2.0 | 93.4±1.8 | 94.5±3.0 | 87.8±5.4 | 96.7±3.5 | 90.6±3.8
4+PCV*** | 83.3±1.0 | 84.2±1.2 | 79.7±3.0 | 83.9±2.3 | 85.3±5.0 | 78.9±6.0 | NA | 83.0±4.7
2+HepA††† | 49.7±1.4 | 45.8±1.6 | 48.6±3.7 | 57.0±3.1 | NA | 50.8±7.5 | NA | 49.8±6.6
Rotavirus‡‡‡ | 59.2±1.4 | 60.2±1.7 | 52.7±3.6 | 60.5±3.2 | NA | 62.6±7.0 | NA | 57.7±6.5
4:3:1§§§ | 82.0±1.1 | 81.5±1.3 | 81.8±2.8 | 82.8±2.5 | 81.1±7.5 | 85.2±4.4 | NA | 81.2±4.9
4:3:1:3llllll | 78.8±1.2 | 78.2±1.5 | 78.0±3.0 | 80.4±2.6 | 79.6±7.6 | 77.6±6.1 | NA | 78.4±5.1
4:3:1:3-PS¶¶¶ | 80.3±1.1 | 79.8±1.5 | 79.3±3.0 | 81.6±2.6 | 80.2±7.6 | 80.2±5.9 | NA | 80.3±5.0
4:3:1:4-FS**** | 62.2±1.3 | 62.5±1.6 | 61.0±3.5 | 61.0±3.2 | 69.8±8.9 | 65.4±7.0 | NA | 65.6±6.1
4:3:1:3:3:1€ | 74.9±1.2 | 73.6±1.5 | 74.5±3.1 | 77.2±2.7 | 77.2±7.8 | 74.4±6.3 | NA | 75.8±5.3
4:3:1:0:3:1ς | 77.8±1.1 | 76.7±1.4 | 77.4±3.0 | 79.4±2.7 | 78.7±7.7 | 81.4±4.8 | NA | 78.4±5.1
4:3:1:3:3:1-PS€€ | 76.3±1.2 | 75.0±1.5 | 75.7±3.1 | 78.3±2.7 | 77.8±7.8 | 76.9±6.0 | NA | 77.7±5.1
4:3:1:4:3:1-FSςς | 59.2±1.3 | 59.0±1.6 | 58.3±3.6 | 58.3±3.2 | 67.4±9.0 | 62.9±7.1 | NA | 63.1±6.1
4:3:1:3:3:1:4€€€ | 70.2±1.3 | 69.9±1.6 | 66.9±3.4 | 72.0±2.9 | 73.1±8.1 | 67.3±6.7 | NA | 73.0±5.4
4:3:1:0:3:1:4ςςς | 72.7±1.2 | 72.7±1.5 | 69.3±3.4 | 74.1±2.8 | 74.5±8.1 | 70.2±6.5 | NA | 75.6±5.2
4:3:1:3:3:1:4-PS€€€€ | 71.5±1.2 | 71.2±1.6 | 68.1±3.4 | 73.2±2.8 | 73.7±8.1 | 69.8±6.5 | NA | 74.9±5.2
4:3:1:4:3:1:4-FSςςςς | 56.6±1.3 | 56.9±1.6 | 54.5±3.6 | 55.5±3.2 | 64.1±9.2 | 59.3±7.2 | NA | 61.3±6.2
 | ^ Estimate=NA (Not Available) if the unweighted sample size for the denominator was <30 or (CI half width)/Estimate > 0.588 or (CI half width) >10. Estimates presented as point estimate (%) ± 95% Confidence Interval.
 | * Self-reported by respondent. Children of Hispanic ethnicity may be of any race.
 | † Children in the Q1/2010-Q4/2010 National Immunization Survey were born from January 2007 through July 2009.
 | ¥  3 or more doses of any diphtheria and tetanus toxoids and pertussis vaccines including diphtheria and tetanus toxoids, and any acellular pertussis vaccine (DTaP/DTP/DT).
 | ‡ 4 or more doses of DTaP.
 | § 3 or more doses of any poliovirus vaccine.
 | ll 1 or more doses of measles-mumps-rubella vaccine.
 | ¶ 3 or more doses of Haemophilus influenzae type b (Hib) vaccine.
 | ** Primary series Hib: ≥2 or ≥3 doses of Haemophilus influenzae type b (Hib), depending on brand type.
 | †† Full series Hib:  ≥3 or ≥4 doses of Hib vaccine depending on product type received (includes primary series plus the booster dose).
 | ‡‡ 3 or more doses of hepatitis B vaccine.
 | §§ 1 or more doses of hepatitis B vaccine administered between birth and age 3 days.
 | llll 1 or more doses of varicella at or after child's first birthday, unadjusted for history of varicella illness.
 | ¶¶ 3 or more doses of pneumococcal conjugate vaccine (PCV).
 | *** 4 or more doses of PCV.
 | ††† 2 or more doses of Hepatitis A vaccine.
 | ‡‡‡ ≥2 or ≥3 doses of [NAME] vaccine, depending on product type received (≥2 doses for Rotarix® [RVI] or ≥3 doses for RotaTeq® [RV5]).
 | §§§ 4 or more doses of DTaP, 3 or more doses of poliovirus vaccine, and 1 or more doses of any MMR vaccine.
 | llllll 4:3:1 plus 3 or more doses of Hib vaccine of any type.
 | ¶¶¶ 4:3:1 plus the primary series Hib.
 | ****  4:3:1 plus the full series Hib.
 | € 4:3:1 plus 3 or more doses of Hib vaccine of any type, 3 or more doses of HepB vaccine, and 1 or more doses of varicella vaccine.
 | ς 4:3:1 plus 3 or more doses of HepB vaccine and 1 or more doses of varicella vaccine. Hib vaccine is excluded.
 | €€ 4:3:1 plus primary series of Hib vaccine, 3 or more doses of HepB vaccine, and 1 or more doses of varicella vaccine.
 | ςς 4:3:1 plus full series of Hib vaccine, 3 or more doses of HepB vaccine, and 1 or more doses of varicella vaccine.
 | €€€ 4:3:1 plus ≥3 doses of Hib vaccine of any type, 3 or more doses of HepB, 1 or more doses of varicella vaccine, and 4 or more doses of PCV.
 | ςςς  4:3:1 plus 3 or more doses of HepB vaccine, 1 or more doses of varicella vaccine, and 4 or more doses of PCV.  Hib vaccine is excluded.
 | €€€€ 4:3:1 plus primary series Hib vaccine, 3 or more doses of HepB, 1 or more doses of varicella vaccine, and 4 or more doses of PCV.
 | ςςςς 4:3:1 plus full series Hib vaccine, 3 or more doses of HepB, 1 or more doses of varicella vaccine, and 4 or more doses of PCV.